Waturu Holding A/S
20.1.2021 16:46:23 CET | Globenewswire | Press release
Company annoucement nr. 51
Fredericia, January 20. 2021
Waturu Holding A/S – resigned auditor sends subsidiary to compulsory dissolution
The Waturu Holding Group is in the process of a change of auditor and in this connection the subsidiary
Waturu ApS has been sent for compulsory dissolution.
The management will immediately ensure resumption through cooperation with the Danish Business
Authority..
About Waturu Holding A/S
Waturu Holding A/S is a Greentech company, which develops innovative water technology for heating or treating water,
with the focus on ensuring bacteria-free water and reducing water and energy consumption for heating hot water in properties and thus ensuring CO2 savings.
Waturu Holding A/S is a major shareholder in the medical company Watgen Medical A/S and in the technology company Aquaturu A/S.
Further information:
CEO Toke Reedtz, cell.: +45 5188 1262, e-mail: toke@waturu.com
Waturu Holding A/S
Sjællandsgade 32
7100 Vejle Certified
Adviser
Tofte & Company ApS
Christian IX Gade 7, 3 rd ,
1111 København
Phone.: +45 71961030
Contact: Sasja Dalgaard, mobile: +45 26100877,
e-mail: sd@toftecompany.com
Website: toftecompany.com
Nasdaq First North Growth Market Important links:
Websites: www.waturu.com
Financial reports: www.waturu.com/documents
Further press related news:
www.linkedin.com/company/waturu/
www.facebook.com/WaturuDenmark/
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
